|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 9/00 | (2006.01) |
| (11) | Number of the document | 2495251 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12169694.2 |
| Date of filing the European patent application | 2004-10-21 | |
| (97) | Date of publication of the European application | 2012-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-16 |
| (46) | Date of publication of the claims translation | 2014-07-25 |
| (30) | Number | Date | Country code |
| 513359 P | 2003-10-22 | US |
| (72) |
Liu, Jyanwei, US
Lee, Junning, US
|
| (73) |
Theravance Biopharma Antibiotics IP, LLC,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Glikopeptido fosfonato darinio hidrochlorido druskos |
| HYDROCHLORIDE SALTS OF A GLYCOPEPTIDE PHOSPHONATE DERIVATIVE |
| Payment date | Validity (years) | Amount | |
| 2018-10-02 | 15 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-10-21 |